NCT05197647进行中（未招募）不适用
Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,085
- 试验地点
- 14
- 主要终点
- One-year utility score of health related quality of life
研究概览
简要总结
The present prospective cohort study aims to assess factors associated with of one-year health-related quality of life and physical, cognitive and mental health outcomes among adult patients with mild COVID-19. Adult patients with symptomatic COVID-19 not requiring hospitalization will be followed through structured and centralized telephone interviews performed at 1, 3, 6, 9 and 12 months after enrollment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥18 years;
- •Positive polymerase chain reaction (PCR) test for SARS-CoV-2;
- •At least one of the following symptoms: fever, cough, sneezing, dyspnea, fatigue, smell alteration, rhinorrhea, sore throat, myalgia, arthralgia, diarrhea;
- •Outpatient COVID-19 care at the moment of enrollment (without indication for in-hospital care).
排除标准
- •Severe comorbidity with life expectancy less than 3 months;
- •Absence of proxy for patients with communication difficulties;
- •Absence of telephone contact;
- •Refusal or withdrawal of agreement to participate;
- •Previous enrollment in the study.
结局指标
主要结局
One-year utility score of health related quality of life
时间窗: The outcome will be assessed 12 months after enrollment.
The outcome will be assessed using the Brazilian version of the Euroqol-5D-3L (EQ-5D3L) questionnaire. The utility score derived from the EQ5D-3L ranges from 0 (death) to 1 (perfect health).
次要结局
- Utility score of health related quality of life at 3, 6, and 9 months(The outcome will be assessed at 3, 6, and 9 months after enrollment.)
- Incidence of all-cause mortality(The outcome will be assessed at 1, 3, 6, 9, and 12 months after enrollment.)
- Prevalence of anxiety and depression symptoms(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
- Incidence of hospitalizations(The outcome will be assessed at 1, 3, 6, 9, and 12 months after enrollment.)
- Prevalence of posttraumatic stress disorder symptoms(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
- Incidence of major cardiovascular events(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
- Incidence of new symptomatic COVID-19 infection(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
- Incidence of return to work or study(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
- Prevalence of prolonged COVID-19 symptoms(The outcome will be assessed at 1, 3, 6, 9, and 12 months after enrollment.)
- Prevalence of cognitive dysfunction(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
- Physical functional status(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
- Instrumental Activities of Daily Living(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
研究者
研究点 (14)
Loading locations...
相似试验
进行中（未招募）
不适用
Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in BrazilCOVID-19Quality of LifeDisability PhysicalDisabilities MentalNCT05165979Hospital Moinhos de Vento650
尚未招募
不适用
Long-Term Outcomes of Different Surgical Techniques for Sacral Tarlov Cysts: A Prospective Cohort StudyNCT06756984Beijing Jishuitan Hospital150
已完成
不适用
A Cohort Study on the Risk Factors and the Long-term Outcomes of Post-Intensive Care Syndrome among Critical Care SurvivorsKCT0004045Dong-A University1,000
终止
不适用
Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2SARS-CoV-2 InfectionBacterial Respiratory Tract InfectionViral Respiratory Tract InfectionNCT04815018Pathnostics185
进行中（未招募）
不适用
Burden of Disease and Functional Impairment in XLHX Linked HypophosphatemiaNCT04946409Wuerzburg University Hospital60